2025-04-01 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Report

**0. Summary of Key Figures:**

* **Cumulative Return (CL):** 42.28%
* **Cumulative Return (VOO):** 91.19%
* **Return Difference (CL vs VOO):** -48.9%
* **Relative Divergence:** 29.1% (indicating CL's performance is below the 29.1th percentile relative to its historical performance against VOO)
* **Current Price:** $93.19
* **5-Day Moving Average:** $91.20
* **20-Day Moving Average:** $91.83
* **60-Day Moving Average:** $89.35
* **RSI:** 39.67 (below 40, suggesting oversold conditions)
* **PPO:** -0.05 (negative, indicating bearish momentum)
* **MRI:** 0.4283 (Low Risk)
* **Expected Return (Long-term):**  -90.9% (significantly underperforms VOO over the long term)


**1. Company Overview and Performance Comparison:**

Colgate-Palmolive Co is a multinational consumer goods company specializing in oral hygiene, personal care, and household products.  Over the analyzed period, CL significantly underperformed the S&P 500 (VOO), with a cumulative return of 42.28% compared to VOO's 91.19%.  This represents a considerable -48.9% difference.  The relative divergence of 29.1% indicates that this underperformance is relatively less extreme than some past periods within the historical data considered.

The provided CAGR and Alpha/Beta data show inconsistent performance. While some periods demonstrate positive alpha (outperforming the market), others show negative alpha, indicating underperformance relative to the market's beta.  Beta consistently hovers around 1, suggesting a similar volatility to the market, though this doesn't fully explain the underperformance. The market cap has generally increased over the years.


**2. Recent Price Movement:**

The current closing price is slightly above the last market price ($93.19 vs $93.41).  The price is below its 5-day, 20-day, and 60-day moving averages, suggesting a downward trend. The recent increase of 0.63 from the previous close may be attributed to short-term fluctuation, but does not change the overall bearish picture.


**3. Technical Indicators and Expected Return:**

The RSI of 39.67 suggests the stock is oversold, potentially indicating a bounce back. However, the negative PPO (-0.05) suggests bearish momentum. The recent relative divergence change of +5.0 indicates short-term upward momentum, counteracting the long-term trends observed.  The market risk indicator (MRI) of 0.4283 suggests low risk; this should be taken with caution in light of the negative expected return. The dramatically negative expected return of -90.9% indicates a significant long-term underperformance relative to the S&P 500.


**4. Recent Earnings Analysis:**

The recent earnings data shows relatively stable revenue around $5 billion, with slight fluctuations. EPS shows a slight decline, before levelling off.  While revenue remained fairly consistent,  more detailed analysis (such as revenue growth and profit margin changes) is needed to accurately gauge the underlying performance trends.  The data is incomplete, with duplicate entries for 2024-10-25.


| Date       | EPS | Revenue     |
|------------|-----|-------------|
| 2024-10-25 | 0.9 | $5.03B      |
| 2024-07-26 | 0.89 | $5.06B      |
| 2024-04-26 | 0.83 | $5.07B      |
| 2023-10-27 | 0.86 | $4.92B      |
| 2024-10-25 | 0.86 | $4.92B      |


**5. Financial Information:**

Revenue has remained relatively stable over the past few quarters, hovering around $5 billion. Profit margins are consistently high (above 60%), indicating strong profitability. However, Equity and ROE show significant volatility, with large swings from quarter to quarter. This high volatility needs further investigation to understand the underlying reasons.



| Quarter    | Revenue | Profit Margin | Equity  | ROE       |
|------------|---------|---------------|---------|-----------|
| 2024-12-31 | $4.95B  | 60.30%        | $0.21B  | 348.58%   |
| 2024-09-30 | $5.03B  | 61.08%        | $0.43B  | 169.43%   |
| 2024-06-30 | $5.06B  | 60.62%        | $0.12B  | 594.31%   |
| 2024-03-31 | $5.07B  | 60.00%        | $0.23B  | 296.96%   |
| 2023-12-31 | $4.95B  | 59.60%        | $0.61B  | 117.90%   |


**6. Overall Analysis:**

Colgate-Palmolive (CL) has shown significant underperformance compared to the S&P 500 (VOO) over the analyzed period. While the company maintains strong profitability margins, the inconsistent performance highlighted by CAGR, Alpha/Beta analysis, and the significantly negative expected return (-90.9% against VOO) raise concerns about long-term investment prospects. The high volatility in Equity and ROE warrants further investigation.  Recent price action shows a downward trend despite a recent short-term bounce.  Technical indicators (RSI and PPO) present a mixed picture, with oversold conditions possibly suggesting a short-term rebound, but this doesn't alleviate the concerns over long-term underperformance.  Further analysis, including a deeper dive into the causes for the ROE volatility and the inconsistencies in the provided earnings data, is needed before making informed investment decisions.
